Civic AI
Procurement intelligence
Federal contract award
[24-014184] THE LAB REQUIRES MYELOID MALIGNANCY SEQUENCING PANEL IN ORDER TO THIS TESTING IS REQUIRED TO MAKE CLINICAL DECISIONS FOR PATIENTS SEEN IN OUR CLINIC, RELATES TO CHOICE OF BONE MARROW TRANSPLANT DONOR OR TREATMENT WITH IMMUNOSUPPRESSION. P
THE UNIVERSITY OF CHICAGO MEDICAL CENTER · Department of Health and Human Services
- Value
- $25,000
- Start
- Jul 11, 2024
- End
- Jan 23, 2026
- Action date
- Jan 23, 2026
- PIID
- 75N92024P00245
- Status
- completed
- NAICS
- 622110 · GENERAL MEDICAL AND SURGICAL HOSPITALS
- Place of performance
- CHICAGO, IL
- Award type
- PURCHASE ORDER
Description
[24-014184] THE LAB REQUIRES MYELOID MALIGNANCY SEQUENCING PANEL IN ORDER TO THIS TESTING IS REQUIRED TO MAKE CLINICAL DECISIONS FOR PATIENTS SEEN IN OUR CLINIC, RELATES TO CHOICE OF BONE MARROW TRANSPLANT DONOR OR TREATMENT WITH IMMUNOSUPPRESSION. P
Need modifications, related awards, and vendor peers? Open the full award workspace.